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A BST R AC T   
 
Aim: This study was designed to evaluate the efficacy of evening primrose oil (EPO) on colonic 
anastomosis.  
Methods: Sixty rats with colonic anastomosis were randomly divided into six groups. EPO and 5-
Fluorouracil (5-FU) were administered at doses of 5 g/kg/day and 20 mg/kg/day, respectively.  Group 
1 served as sham control. The rats in Group 2 (EPO) received EPO (14 days preoperatively), in Group 
3 (Extended EPO) received EPO (14 days preoperatively and 7 days postoperatively), in Group 4 (5-
FU) received intraperitoneally 5-FU (5 days preoperatively), in Group 5 (5-FU+EPO) received EPO 
(14 days preoperatively), and 5-FU (5 days preoperatively), in Group 6 (5-FU+ extended EPO) 
received EPO (14 days preoperatively and 7 days postoperatively)  and 5-FU (5 days preoperatively). 
Histopathological examination, bursting pressure, and hydroxyproline content were used for 
evaluation.  
Results: Significant differences were found between the Groups 1, 2, and 3 and Groups 4, 5, and 6 
in bursting pressures. Polymorphonuclear leukocyte (PMNL) and lymphocyte infiltration was 
significantly less in group 3, compared to the control and group 2. The least PMNL infiltration was 
in group 6 compared to groups 4 and 5.  The hydroxyproline level was different in group 3 compared 
to the control and group 2. Furthermore, groups 5 and 6 were different compared to group 4.  
Conclusion: EPO had  favorable effects on colonic anastomosis even in groups where 5-FU was 
used.  
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Introduction 
Anastomotic leakage is a major problem that 
significantly increases mortality and morbidity 
in colorectal surgery. The incidence is 0.5-30% 
in the literature [1,2]. A mortality rate of 25-
37% has been reported due to anastomotic 
leakage in a large series [3]. Anastomotic 
failure increases the duration of hospitalization 
2-fold and perioperative mortality 3-fold [4]. 
Therefore, research is focused on a variety of 
systemic or local interventions with the hope of 
favorable effects on anastomosis healing [1,2,4-
6].  
5-fluorouracil (5-FU) application has been 
regarded as the standard chemotherapy agent 
for colorectal cancer for a long time [7]. The 
postoperative intraperitoneal application of 5-
FU is known to clear disseminated cancer cells 
and eradicate micrometastases [4,8]. However, 
5-FU has also been shown to negatively affect 
healing in colonic anastomosis in several 
studies [9-11]. It was shown that 5-FU increases 
inflammatory reaction, reduces the fibroblast 
and collagen formation and neovascularization 
at the anastomotic site [11].  
Evening primrose oil (EPO) is rich in omega-
six and essential fatty acids such as linoleic acid 
(LA) and gamma linoleic acid (GLA). These 
fatty acids are prostaglandin precursors and 
used in the production of prostaglandin-E1 
(PGE1) exogenously [12]. PG-E1 has been 
demonstrated to favorably affect anastomotic 
healing in various studies [13-15]. PG-E1 
exerts its effect by promoting the collagen 
synthesis and decreasing the inflammatory cell 
infiltration that negatively affect the process of 
anastomotic healing [14,15].  
EPO, as a rich PG-E1 source, has vasodilator, 
anti-oxidative and anti-inflammatory effects 
when used in high doses [12]. It has been the 
subject of many studies due to its effects and 
found a place in the treatment of many diseases 
[16-18]. However, to the best of our knowledge, 
its effects on anastomotic healing has yet to be 
elucidated. The aim of this study is to evaluate 
the effects of EPO on colonic anastomosis in a 
rat experiment.  
 
Materials and Methods 
This study was approved by the Ethics Board of 
19 Mayıs University, School of Medicine 
(Dated 29.01.2013 and issue number 2013/07). 
In addition to standard groups, rat groups who 
were subjected to the effects of 5-FU were 
created. Therefore, the efficacy of EPO was 
evaluated in the presence of an agent that is 
known to have unfavorable effects on 
anastomotic healing. 
Sixty male Wistar albino rats, weighing 250-
300 g, were used in the study. The subjects were 
fed with tap water, standard animal feed, and 
EPO and were kept in a laboratory 
environment. A cocktail with ketamine 
(Ketalar®, Parke-Davis, Eczacıbaşı), 80 mg/kg 
and xylazine (Rompun®, Bayer), 8 mg/kg was 
used intraperitoneally as anesthetic agent. 
Following appropriate field cleansing and 
placing sterile sheets, a midline incision, 3-3.5 
cm in length was performed. A colon resection, 
1 cm in thickness, was carried out in the middle 
part of the transverse colon and an end-to-end 
anastomosis was created using a 5/0 
polyprolene suture. The abdominal incision 
was closed using a 3/0 silk suture. 
The rats were randomly divided into six groups 
(Figure 1).  Group 1 (control) received standard 
feed for 14 days preoperatively and 7 days 
postoperatively. The rats in Group 2 (EPO) 
received EPO, 5 g/kg/day through gavage for 
14 days preoperatively in addition to standard 
feed. Rats were fed with standard feed for 7 
days postoperatively. The rats in Group 3 
(Extended EPO) received EPO, 5 g/kg/day 
through gavage for 14 days preoperatively and 
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7 days postoperatively in addition to standard 
feed. The rats in Group 4 (5-FU) received 
intraperitoneally 20 mg/kg 5-FU (Biosyn ®, 
Orna) diluted in 3 ml saline solution for 5 days 
preoperatively and resection and anastomosis 
was performed after an interval of 1 day. 
Subjects were fed with standard feed for 7 days 
postoperatively. The rats in Group 5 (5-
FU+EPO) received EPO, 5 g/kg/day for 14 
days and also intraperitoneally 20 mg/kg 5-FU 
diluted in 3 ml saline solution for 5 days 
preoperatively. Subsequently one day interval 
was given and resection and anastomosis were 
performed. Subjects were fed with standard 
feed for 7 days postoperatively. The rats in 
Group 6 (5-FU+ extended EPO) received EPO, 
5 g/kg/day for 14 days and also 
intraperitoneally 20 mg/kg 5-FU diluted in 3 ml 
saline solution for 5 days preoperatively. 
Subsequently, a one-day interval was given and 
resection and anastomosis were performed. 
Subjects were fed with EPO, 5 g/kg/day 
through gavage in addition to standard feed for 
7 days postoperatively. Rats were sacrificed 
after seven days postoperatively and after 12 
hours of fasting, relaparotomies were 
performed. 
 
Bursting pressure 
Following relaparotomy, a segment of the 
colon, measuring 5 cm in length, 2.5 from each 
direction from the anastomosis, was resected 
carefully. This segment of the transverse colon 
was cleaned of feces and the distal end was tied 
with a 3/0 silk suture. A catheter connected to a 
sphygmomanometer was inserted to the 
proximal end and colon was carefully tied 
around the tube. A solution of 0.9% NaCl was 
infused at a constant speed of 1ml/min through 
the catheter. The level of pressure seen when 
the leakage appeared at the anastomosis was 
recorded. All the bursting pressures were 
evaluated immediately after the rats were 
sacrificed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Diagram of experimental design. 
 
Histopathological examination 
Following the recording of the bursting 
pressure, the anastomosis line was resected, 
including approximately 0.5 cm proximal and 
distal colonic segments. The resected segment 
of colon was divided into two parts in equal 
lengths and one of the pieces was placed in a 
10% buffered neutral formalin solution for 
histopathological examination. Evaluation was 
performed after staining with Hematoxylin 
Eosin (HE) using a semi-quantitative scale 
including many parameters related to wound 
healing, as defined by Biert et al. [19] (Table 1).  
According to this scale, the amount of necrosis 
was expressed as none (0 points), only small 
patches (1 point), some patches (2 points), or 
massive (3 points). In the anastomotic area, 
accumulation of polymorphonuclear cells 
(PMNs), macrophages, and lymphocytes was 
also assessed in terms of none or normal (0 
points), slightly increased (1 point), marked 
infiltration (2 points), and massive infiltration 
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(3 points). Edema, expressed as the ratio of 
maximum thickness of the wall at the 
anastomosis and the thickness of the normal 
colon wall at the end of the section, was  graded 
as none (0 points), some (1–1.5× normal 
thickness; 1 point), marked (1.5–2× normal 
thickness; 2 points) and severe (> 2x normal 
thickness; 3 points). Healing of the mucosa was 
expressed as normal, i.e. mucosa with restored 
glandular epithelium (0 points), intact mucosa 
with cubic epithelium but without glands (1 
point), mucosa only partially covered by cubic 
epithelium (2 points), and mucosa completely 
devoid of epithelial coverage (3 points). 
Submucosal-muscular repair was assessed in 
terms of good (0 points), average (1 point), poor 
(2 points), or no (3 points) fibroblast stretching 
and bridging the anastomotic wound. This way, 
in each anastomosis, two observations from the 
mesenteric and two from the anti-mesenteric 
side were performed. 
 
Hydroxyproline 
The second piece taken from the anastomotic 
line was manually homogenized applying 
liquid nitrogen in a porcelain mortar and placed 
in an appropriately buffered phosphate solution 
(Phosphate Buffer Solution, 10 mM, pH 7.2).  
Following the sonication of the tissue samples 
for 1 minute in +4°C at 220V (Fisher, Sonic 
 
 
 
 
 
 
 
 
 
 
 
 
Dismembrator; Mosel 300), they were stored in 
a freezer at -80 °C. Homogenates were 
centrifuged at +4°C at 14000 rpm for 5 minutes 
and the obtained supernatants were used for 
analysis. Hydroxyproline levels were 
determined using a BioVision commercial kit 
(BioVision, CA, USA, Cat.No.#K555-100) 
based on reading at 560 nm of chromogen, 
which is formed as a result of a 
spectrophotometric reaction. The protein 
content of each sample in tissue homogenates 
was determined using the Lowry method [20] 
and levels of hydroxyproline were expressed in 
ng per mg protein (ng/mg.prot). 
 
Statistical analysis 
When Groups I, II, and III and Groups IV, V, 
and VI were compared within groups, and the 
characteristics of hydroxyproline and bursting 
pressure were evaluated one-way analysis 
variance (ANOVA) was used. Levene’s 
homogeneity test was used to detect the 
homogeneity of the variances.  
The Kruskal-Wallis test was used in the 
analysis of other features. The analysis of 
hydroxyproline levels and bursting pressure 
characteristics were performed using 
independent sample t-test in inter-group 
comparisons. The Mann-Whitney U-test was 
used in the analysis of other 
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characteristics. P values <0.05 were accepted as 
statistically significant. 
 
Results  
 
Bursting pressure 
The highest bursting pressure values were 
measured in the extended EPO group (198.0 ± 
7.48). The lowest bursting pressures were in the 
5-FU     group    (119.89 ± 2.88).    Statistically  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
significant differences were found between the 
intergroup analysis of Groups I, II, and III and 
between Groups IV, V, and VI (p<0.001) 
(Table 2). 
Differences were reported between the control 
group and 5-FU group and between the EPO 
group and 5-FU+EPO group, as well (p<0.001). 
In addition, statistically significant differences 
were found between the extended EPO and 5-
FU+ extended EPO groups (p=0.002) (Table 3). 
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Histopathological examination 
When the control, EPO and extended EPO 
groups were compared, it was observed that 
PMNL and lymphocyte infiltration was 
significantly lower in the extended EPO group 
compared to the other two groups (p=0.003, 
and p=0.020). No differences were found in 
other histopathological examination criteria 
(Table 4). When the groups with 5-FU were 
compared, a significant difference between all 
groups was found in only the PMNL 
infiltration. The lowest PMNL infiltration was 
in the 5-FU+extended EPO group and was 
different from the other two groups (p=0.029). 
Other criteria of histopathological examination 
were found to be similar in the groups (Table 
4). Figures 2-4 show histopathological changes 
and inflammatory findings in different 
treatment groups.   
When the groups with and without 
chemotherapeutic agents were comparatively  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
analyzed, significant differences were found in 
macrophage infiltration, edema formation, and 
mucosal epithelial structure between the control 
and 5-FU groups (p=0.005, p=0.025, and 
p=0.008, respectively). Macrophage infiltration 
and mucosal epithelial damage was 
significantly higher in the 5-FU group. In 
addition, more edema development was seen in 
this group. Mucosal epithelial structure was 
different in the EPO and 5-FU+EPO groups. 
The mucosal epithelial damage was more 
severe in the 5-FU+EPO group (p=0.030). 
When the extended EPO and 5-FU+extended 
EPO groups were compared, edema 
development and mucosal epithelial damage 
was significantly greater in the 5-FU+extended 
EPO group (p=0.005 and p=0.048, 
respectively). Other histopathological 
evaluation criteria were similar in all groups 
(Table 5). 
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Hydroxyproline 
Hydroxyproline levels in the extended EPO 
group was different when compared to the 
control and EPO groups (p=0.014). The 5-
FU+EPO and 5-FU+extended EPO groups 
were also significantly different from the 5-FU 
groups, as well (p=0.002) (Table 2). 
When the groups with and without 
chemotherapeutic agents were comparatively 
evaluated, differences were found between the 
control and 5-FU groups and between EPO and 
5-FU+EPO (p=0.045 and p=0.023, 
respectively) (Table 3). 
 
Discussion 
The salient finding of the present study was that 
EPO demonstrated beneficial therapeutic 
effects of on colonic anastomosis in rats. These 
favorable effects were still prominent in the 
presence of 5-FU that has deleterious effects on 
the anastomosis.  
Anastomotic leakage after colorectal surgery is 
reported to be seen in up to 30% of the cases. 
[1,2,4,9]. In spite of the advances in the 
operative techniques and patient preparation 
procedures it is still a significant cause of 
postoperative morbidity and mortality [3].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anastomotic healing is a complex process 
including a series of biological events. 
Coordination of cellular activity and humoral 
factors is necessary during this process [21]. 
Anastomotic healing is affected by the degree 
of the inflammatory response and the rate of 
mucosal re-epithelization, thus the power, 
quantity, and maturation rate of the collagen. 
Durability of the anastomosis line is basically 
dependent on the collagen fibrils and their 
degree of maturation in the submucosa [22]. 
We found that administration of EPO had a 
clear beneficial effect on both bursting 
pressures and hydroxyproline content. 
Hydroxyproline content was significantly 
higher in the extended EPO group compared to 
the other groups on the seventh day when we 
expected the collagen synthesis to be at its 
highest level. We also observed that 5-FU 
significantly decreased the hydroxyproline 
content. The adverse effect of 5-FU on 
fibroblast proliferation and collagen synthesis 
is well-known [7]. On the contrary, the 
observed higher hydroxyproline content in the 
5-FU+EPO and 5-FU+extended EPO groups 
compared to the 5-FU group demonstrated that 
EPO reverses the deleterious effects of 5-FU. 
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Experimental studies have demonstrated that 
the hydroxyproline concentrations decrease in 
the anastomotic lines after colonic resections 
[15]. Hawley et al. [23] emphasized that the 
collagenase enzyme was responsible for the 
observed decrease in the level of 
hydroxyproline. Hawley et al. demonstrated 
that the production of this enzyme was 
increased both in the area of anastomosis and 
also in other parts of gastrointestinal system. 
This is a primary factor causing weakness of the 
anastomosis by increasing collagen breakdown. 
Therefore, the production and breakdown of 
collagen during the healing phase of the 
anastomosis should be well balanced. 
The authors have stressed that it is necessary to 
prevent low suture tension, good local blood 
flow, weak local inflammation, and to reduce 
feces by a lavage of colon preoperatively for a 
good anastomotic healing after colonic surgery. 
These factors may have an effect on collagen 
synthesis by inhibiting collagenase. As a result, 
collagen content in the intestinal wall plays a 
major role in anastomotic healing and the 
prevention of complications such as leakage 
[15]. 
Since fibroblast proliferation and collagen 
synthesis occur in the submucosal layer, 
anastomotic strength primarily depends on the 
collagen fibrils in the submucosa, as stated 
above [21]. Maximal collagen synthesis occurs 
in the 5-7th days during the proliferation of 
local fibroblasts which produce collagen [22]. 
Therefore, this study was terminated on the 7th 
day, taking into account the experimental 
models in the literature [22,24]. 
EPO is a product that has been used for years as 
a dietary supplement and an alternative 
treatment in various diseases [12,16]. It is most 
commonly used in the treatment of diseases 
with chronic inflammation. Atopic dermatitis, 
rheumatoid arthritis, mastalgia, menopausal 
and premenstrual symptoms, cervical ripening, 
and birth induction are some of the conditions 
for which it is frequently used [16-18]. It is rich 
from omega-6 essential fatty acids such as LA 
and GLA, which are used in the production of 
PGE1 in the body [12]. Orally administered 
EPO has been proven to demonstrate 
vasodilator, anti-oxidative, and anti-
inflammatory efficacy in various experimental 
studies [12,25]. Abo-Gresha et al. [12] 
demonstrated the healing effect of EPO in rats 
with experimentally-induced myocardial 
infarction. In that study, in addition to the 
antithrombotic activity of PGE1, which is 
synthesized from the fatty acids in EPO, it is 
reported to cause smooth muscle relaxation and 
vasodilation. Furthermore, PGE1 was reported 
to decrease oxidative stress and inflammation 
in the ischemic heart. El-Sayed et al. [25] on the 
other hand, in their experimental study, in 
which they evaluated the progression of 
rheumatoid arthritis, reported that EPO has a 
marked anti-inflammatory effect. In addition, 
they recorded that GLA, which increases the 
production of PGE1 in the body had a role in 
the anti-inflammatory and anti-oxidative 
effects. In experimental studies, the 
predominant vasodilator, anti-inflammatory 
and wound healing effects of PGE1 have been 
emphasized. Goertz et al. [26] evaluated the 
effects of various agents such as acetylsalicylic 
acid, isosorbide dinitrate, sodium chloride, and 
PGE1, which were considered to have 
treatment effect in rats with experimentally 
produced burns. The most successful results 
were obtained in the PGE1 group. PGE1 was 
proven to increase angiogenesis and blood flow 
and at the same time to demonstrate anti-
inflammatory effects by decreasing rolling 
leukocytes in the circulation. Its effects on 
augmentation of wound healing by increasing 
perfusion through inducing vasodilation, 
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inhibiting thrombocyte aggregation, and thus 
delaying thrombus formation have also been 
reported. Kobayashi et al. [27] also 
demonstrated that PGE1, in addition to its 
vasodilator and anti-aggregating effects on 
thrombocytes, proliferates the production of 
epidermal keratinocytes and dermal fibroblasts. 
In addition, they reported that PGE1 was an 
anti-oxidative agent and all of its characteristic 
features have a positive effect on wound 
healing. 
The limitation of the current work deserves to 
be stated. We applied 5-FU and EPO in a single 
dose in all groups. We determined the dose of 
EPO as 5 g/kg/day based on the results of 
previous studies in the literature [25,28,29], in 
which the dose of EPO varied between 1.25-10 
g/kg/day and for an average of 14-28 days. We 
also determined the dose and duration of 5-FU 
in the appropriate groups according to the 
previous studies [7,10]. To limit the number of 
scarified animals and not to increase 
complexity of the experimental model, we 
opted for using a single EPO and 5-FU dose in 
the study.  
For the first time in the literature, we evaluated 
the effects of EPO administered through the 
gavage method on colonic anastomosis in an 
experimental study. We administered the agent 
for 14 days preoperatively and 7 days 
postoperatively in the respective groups.  
 
Conclusions 
In conclusion, we demonstrated beneficial 
therapeutic effects of EPO on colonic 
anastomosis in rats. This was likely due to the 
essential fatty acid content of EPO because 
these fatty acids are used in the production of 
PGE1 in the body. The anti-inflammatory, 
vasodilator and anti-oxidative effects of EPO 
might favorably influence the anastomosis. The 
maintenance of these favorable effects in spite 
of the presence of an agent that has deleterious 
effects on the anastomosis such as 5-FU 
suggests that EPO use might be employed to 
decrease the rate of anastomotic leakage in 
patients who receive neoadjuvant 
chemotherapy and are scheduled to undergo 
surgical treatment. 
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